Logo image of AFRI

FORAFRIC GLOBAL PLC (AFRI) Stock Fundamental Analysis

NASDAQ:AFRI - Nasdaq - GI000A3DNK69 - Common Stock - Currency: USD

7.8  -0.04 (-0.51%)

Fundamental Rating

1

Overall AFRI gets a fundamental rating of 1 out of 10. We evaluated AFRI against 89 industry peers in the Food Products industry. Both the profitability and financial health of AFRI have multiple concerns. AFRI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

AFRI had negative earnings in the past year.
AFRI had a positive operating cash flow in the past year.
In the past 5 years AFRI always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: AFRI reported negative operating cash flow in multiple years.
AFRI Yearly Net Income VS EBIT VS OCF VS FCFAFRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

AFRI has a worse Return On Assets (-9.89%) than 75.28% of its industry peers.
Industry RankSector Rank
ROA -9.89%
ROE N/A
ROIC N/A
ROA(3y)-6.73%
ROA(5y)-4.58%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AFRI Yearly ROA, ROE, ROICAFRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

The Gross Margin of AFRI (9.97%) is worse than 75.28% of its industry peers.
In the last couple of years the Gross Margin of AFRI has declined.
AFRI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.95%
GM growth 5Y-12.55%
AFRI Yearly Profit, Operating, Gross MarginsAFRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

2

2. Health

2.1 Basic Checks

AFRI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AFRI has about the same amount of shares outstanding.
Compared to 5 years ago, AFRI has less shares outstanding
The debt/assets ratio for AFRI is higher compared to a year ago.
AFRI Yearly Shares OutstandingAFRI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
AFRI Yearly Total Debt VS Total AssetsAFRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

AFRI has an Altman-Z score of 0.16. This is a bad value and indicates that AFRI is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.16, AFRI is doing worse than 74.16% of the companies in the same industry.
The Debt to FCF ratio of AFRI is 7.35, which is on the high side as it means it would take AFRI, 7.35 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.35, AFRI is in the better half of the industry, outperforming 68.54% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.35
Altman-Z 0.16
ROIC/WACCN/A
WACC7.6%
AFRI Yearly LT Debt VS Equity VS FCFAFRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

AFRI has a Current Ratio of 0.37. This is a bad value and indicates that AFRI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of AFRI (0.37) is worse than 93.26% of its industry peers.
A Quick Ratio of 0.30 indicates that AFRI may have some problems paying its short term obligations.
AFRI has a Quick ratio of 0.30. This is amonst the worse of the industry: AFRI underperforms 88.76% of its industry peers.
Industry RankSector Rank
Current Ratio 0.37
Quick Ratio 0.3
AFRI Yearly Current Assets VS Current LiabilitesAFRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

AFRI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -91.04%.
Looking at the last year, AFRI shows a decrease in Revenue. The Revenue has decreased by -9.18% in the last year.
The Revenue has been growing by 8.40% on average over the past years. This is quite good.
EPS 1Y (TTM)-91.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-91.04%
Revenue 1Y (TTM)-9.18%
Revenue growth 3Y1.57%
Revenue growth 5Y8.4%
Sales Q2Q%-9.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AFRI Yearly Revenue VS EstimatesAFRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 100M 200M 300M

2

4. Valuation

4.1 Price/Earnings Ratio

AFRI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AFRI Price Earnings VS Forward Price EarningsAFRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

AFRI's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. AFRI is more expensive than 65.17% of the companies in the same industry.
AFRI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AFRI is cheaper than 87.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.67
EV/EBITDA 66.3
AFRI Per share dataAFRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AFRI!.
Industry RankSector Rank
Dividend Yield N/A

FORAFRIC GLOBAL PLC

NASDAQ:AFRI (6/4/2025, 11:30:35 AM)

7.8

-0.04 (-0.51%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-13 2022-11-13/bmo
Earnings (Next)12-13 2022-12-13/bmo
Inst Owners2.03%
Inst Owner Change-6.09%
Ins Owners1.92%
Ins Owner ChangeN/A
Market Cap209.82M
AnalystsN/A
Price TargetN/A
Short Float %9.8%
Short Ratio18.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.77
P/FCF 9.67
P/OCF 8.94
P/B N/A
P/tB N/A
EV/EBITDA 66.3
EPS(TTM)-0.9
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.81
FCFY10.34%
OCF(TTM)0.87
OCFY11.18%
SpS10.19
BVpS-0.06
TBVpS-1.82
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.89%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 9.97%
FCFM 7.91%
ROA(3y)-6.73%
ROA(5y)-4.58%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.95%
GM growth 5Y-12.55%
F-Score4
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.35
Debt/EBITDA 47.36
Cap/Depr 29.39%
Cap/Sales 0.65%
Interest Coverage N/A
Cash Conversion 714.99%
Profit Quality N/A
Current Ratio 0.37
Quick Ratio 0.3
Altman-Z 0.16
F-Score4
WACC7.6%
ROIC/WACCN/A
Cap/Depr(3y)91.45%
Cap/Depr(5y)82.26%
Cap/Sales(3y)1.79%
Cap/Sales(5y)1.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-91.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-91.04%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.18%
Revenue growth 3Y1.57%
Revenue growth 5Y8.4%
Sales Q2Q%-9.18%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-322.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-8.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-29.59%
OCF growth 3YN/A
OCF growth 5YN/A